FDA newly confirmed to be presenting on the program!
The dermatology space continues to strive in therapeutic innovation. There’s been a transformative evolution in the understanding of the pathophysiology of skin diseases, and in the available treatment options for chronic, moderate to severe dermatological conditions that affect lives of millions of patients worldwide.
The 2nd annual Dermatology Drug Development Summit provides a unique forum for industry leaders to take advantage of this tremendous environment of opportunity driven by huge investments to innovate and bring better and more efficient drugs to market, for the treatment of high unmet need.
Leading organizations and experts in this space will share their exclusive insight in an end-to-end discussion sharing pharmaceutical best practice and the latest case-studies on the development and bringing to market of new and innovative dermatological drugs.
Join them to collaboratively tackle specific challenges you face in developing these drugs – from strategic concerns, to discovery, preclinical activities, formulation and delivery strategies, biologic therapies, clinical development, regulatory and commercial hurdles – and uncover the details behind the latest developments in this space.